Clinical Trial Update: Surgery Plus Medroxyprogesterone in Preventing Endometrial Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing surgery plus medroxyprogesterone to prevent endometrial cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Medroxyprogesterone (medroxyprogesterone)

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Endometrial Cancer | Phase 2 | Status: TERMINATED